Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 8/20 | 1.00 |
| ▸ | CES2 | O00748 | 7/20 | 1.00 |
| ▸ | CA1 | P00915 | 1/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | TP53 | P04637 | 1/20 | 0.58 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.50 |
| ▸ | PPARG | P37231 | 3/20 | 0.48 |
| ▸ | PPARD | Q03181 | 3/20 | 0.48 |
| ▸ | PPARA | Q07869 | 3/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.48 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.48 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.48 |
| ▸ | TLR2 | O60603 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | ESR1 | P03372 | 1/20 | 0.48 |
| ▸ | FABP4 | P15090 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL534976 | 0.94 | CES1 (0.88) | CES1CES2CA1ALDH1A1TP53 | |
| SCHEMBL534936 | 0.94 | CES1 (0.94) | CES1CES2CA1ALDH1A1AKR1B1 | |
| SCHEMBL23736175 | 0.91 | CES1 (0.94) | CES1CES2ALDH1A1PPARGPPARD | |
| SCHEMBL10338728 | 0.91 | CES1 (0.94) | CES1CES2ALDH1A1PPARGPPARD | |
| SCHEMBL534999 | 0.91 | CES1 (0.82) | CES1CES2CA1ALDH1A1TP53 | |
| SCHEMBL3293052 | 0.90 | CES1 (1.00) | CES1CES2ALDH1A1AKR1B1PPARG | |
| SCHEMBL27896652 | 0.87 | CES1 (0.77) | CES1CES2CA1ALDH1A1TP53 | |
| SCHEMBL1286262 | 0.87 | CES2 (1.00) | CES1CES2ALDH1A1PPARGPPARD | |
| SCHEMBL11438920 | 0.87 | CES2 (1.00) | CES1CES2ALDH1A1PPARGPPARD | |
| SCHEMBL6849632 | 0.87 | CES2 (1.00) | CES1CES2ALDH1A1PPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110514650-B | Chemiluminescence analysis determination method, system and kit using same | 科美博阳诊断技术(上海)有限公司 | 2023-01-24 | — | — | CN | claimed |
| CN-110514646-B | Chemiluminescence analysis determination method, system and kit using same | 科美博阳诊断技术(上海)有限公司 | 2023-01-20 | — | — | CN | claimed |
| CN-110514647-B | Chemiluminescence analysis determination method, system and kit using same | 科美博阳诊断技术(上海)有限公司 | 2023-01-20 | — | — | CN | claimed |
| CN-115141593-A | Adhesive for formaldehyde-free plant fibers and preparation method thereof | 郦玉孺 | 2022-10-04 | — | — | CN | claimed |
| CN-112240936-A | Application of donor reagent in diagnosis of myocardial damage of main body | 博阳生物科技（上海）有限公司 | 2021-01-19 | — | — | CN | claimed |
| CN-112240937-A | Application of donor reagent in diagnosis of main body infected bacterial inflammatory disease | 博阳生物科技（上海）有限公司 | 2021-01-19 | — | — | CN | claimed |
| CN-112240929-A | Donor particle for homogeneous phase chemiluminescence analysis and application thereof | 博阳生物科技（上海）有限公司 | 2021-01-19 | — | — | CN | claimed |
| CN-112114149-A | Application of receptor reagent in diagnosis of myocardial damage of main body | 博阳生物科技（上海）有限公司 | 2020-12-22 | — | — | CN | claimed |
| CN-112114130-A | Receptor reagent for homogeneous phase chemiluminescence detection and application thereof | 博阳生物科技（上海）有限公司 | 2020-12-22 | — | — | CN | claimed |
| CN-111665237-A | Homogeneous phase chemiluminescence detection method and application thereof | 上海索昕生物科技有限公司 | 2020-09-15 | — | — | CN | claimed |
| CN-111665235-A | Chemiluminescent microarray chip and application thereof | 上海索昕生物科技有限公司 | 2020-09-15 | — | — | CN | claimed |
| CN-111665238-A | Application of chemiluminescence microarray chip | 上海索昕生物科技有限公司 | 2020-09-15 | — | — | CN | claimed |
| CN-111122843-A | Homogeneous phase chemiluminescence detection kit | 博阳生物科技（上海）有限公司 | 2020-05-08 | — | — | CN | claimed |
| CN-111122871-A | Homogeneous detection kit and method for triiodothyronine and application | 博阳生物科技（上海）有限公司 | 2020-05-08 | — | — | CN | claimed |
| CN-110823872-A | Microsphere composition for chemiluminescence analysis and application thereof | 博阳生物科技（上海）有限公司 | 2020-02-21 | — | — | CN | claimed |
| EP-0349204-A2 | Use and regeneration of reagents using coupled reactions and permselective barriers | BEND RESEARCH, INC. (US) | 1990-01-03 | — | — | EP | claimed |
| US-20260079169-A1 | VOLATILE ORGANIC COMPOUNDS AS MARKERS FOR CELLULAR COMMUNICATION | TECHNION RES & DEV FOUNDATION (IL) | 2026-03-19 | — | — | US | disclosed |
| CN-110514647-B | Chemiluminescence analysis determination method, system and kit using same | 科美博阳诊断技术(上海)有限公司 | 2023-01-20 | — | — | CN | disclosed |
| WO-1997033854-A1 | PROCESS TO PREPARE A TERMINAL ALDEHYDE | DSM N.V. (NL) | 1997-09-18 | — | — | WO | disclosed |
| US-4306872-A | Imidazolidinones in a durable press process | AMERICAN CYANAMID COMPANY (US) | 1981-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260079169-A1 | VOLATILE ORGANIC COMPOUNDS AS MARKERS FOR CELLULAR COMMUNICATION | BCL2, BAX, EPCAM | CES1 1316/4885CES2 1201/4885CA1 402/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.